Consulting Wallah › Device Explorer › Other devices › Antiseizure/psychiatric-therapy vagus nerve implan
Device Explorer · FDA GUDID · GMDN 34210

Antiseizure/psychiatric-therapy vagus nerve implantable electrical stimulation system

An assembly of battery-powered devices intended to apply periodic electrical stimuli to the vagus nerve to help control seizures and/or to help treat psychiatric disorder symptoms (e.g., depression). The vagus nerve stimulation (VNS) is provided through an imp

US‑registered devices58in commercial distribution
Companies3labelers on GUDID
Single‑use55%of device records
Sterile55%labelled sterile
Prescription100%Rx‑only share
ImplantableYesGMDN flag
ShareLinkedIn

Share of device records

Inspire Medical Systems, Inc.4679%
Livanova Usa, Inc.1017%
Microtransponder23%

Top labelers

CompanyDevicesShare
Inspire Medical Systems, Inc.4679%
Livanova Usa, Inc.1017%
Microtransponder23%

Company = labeler of record on GUDID. 3 companies in total; top 12 shown. Click headers to sort.

Brand names on the register (sample)

VNS Therapy® SenTiva Duo™ Model 1000-D GeneratorVNS Therapy® Symmetry™ Model 8103 GeneratorVNS Therapy® SenTiva™ Model 1000 GeneratorVNS Therapy® Model 502 Accessory PackVNS Therapy® AspireSR® Model 106 GeneratorVNS Therapy® AspireHC® Model 105 GeneratorVNS Therapy® Demipulse Duo® Model 104 GeneratorVNS Therapy® Demipulse® Model 103 GeneratorVNS Therapy® Pulse Duo Model 102R GeneratorVNS Therapy® Pulse Model 102 GeneratorInspirePaired VNSVivistim®

Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.

FDA product codes

CodeNameDevices
MNQStimulator, Hypoglossal Nerve, Implanted, Apnea46
MUZStimulator, Autonomic Nerve, Implanted (Depression)9
LYJStimulator, Autonomic Nerve, Implanted For Epilepsy9
QPYStimulator, Autonomic Nerve, Implanted For Stroke Rehabilita2

GMDN & GCC registration

  • GMDN code 34210 · implantable
  • Single‑use 55% · sterile 55% · Rx‑only 100% · OTC 0%
  • UAE: MOHAP / DoH medical device registration and an authorised representative are required; Saudi: SFDA MDMA. We check status on request.

Size attributes recorded

No structured size data on the register.

Use these as the dimensions to specify in a tender line.

No closely related category with 50+ devices.

How many antiseizure/psychiatric-therapy vagus nerve implantable electrical stimulation system products are registered in the US?

58 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Antiseizure/psychiatric-therapy vagus nerve implantable electrical stimulation system", from 3 companies. The largest labeler is Inspire Medical Systems, Inc. with 79% of records.

Which FDA product codes apply?

MNQ (Stimulator, Hypoglossal Nerve, Implanted, Apnea), MUZ (Stimulator, Autonomic Nerve, Implanted (Depression)), LYJ (Stimulator, Autonomic Nerve, Implanted For Epilepsy), QPY (Stimulator, Autonomic Nerve, Implanted For Stroke Rehabilita)

Is this the same as UAE/GCC registration?

No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.

How do I get quotes?

Add antiseizure/psychiatric-therapy vagus nerve implantable electrical stimulation system to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.

Request quotes for Antiseizure/psychiatric-therapy vagus nerve implantable electrical stimulation system

Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.

Buying antiseizure/psychiatric-therapy vagus nerve implan for a hospital group?Free executive assessment: we benchmark your prices and tender structure against the Network.
Book the free assessment

Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.

Get quotes →